The European Medicines Agency (EMA) on Wednesday gave the nod to Moderna’s COVID-19 vaccine, paving the way for its final authorisation by the European Commission.
The conditional market authorisation of the vaccine jab developed by the US biotechnology company Moderna will mark the bloc’s second vaccine against Coronavirus, as in December, the EU’s medicines watchdog approved the candidate developed by Pfizer and its German partner, BioNTech.
“This vaccine provides us with another tool …
This story is part of New Europe’s Premium content.
| To Read the Full Story, Subscribe or Sign In from the ↑ Top of the Page ↑ |
In this article:
